NASDAQ:INDP 24 December 2025

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics announced a $6 million preferred-stock financing with investor David Lazar, who will become chairman and co-CEO. The deal could add up to 111 million common shares if converted, pending shareholder approval. Shares jumped over 60% after hours on December 23, 2025, following the news, after closing at $1.95 in regular trading. Two directors resigned as part of the boardroom changes.

24 December 2025

Biotechnology·NASDAQ:INDP·Stock Market

US Stocks, Bonds, and Gold Slide Amid Iran Conflict and Rising Oil Prices
March 20, 2026, 4:11 PM EDT. US stocks and bonds declined sharply as the Iran war intensified, pushing oil prices up and gold to its worst week in 40 years. The Russell 2000 index fell 2.7%, nearing correction territory (a 10% drop from peak). The Dow dropped 444 points (0.96%), S&P 500 fell 1.51%, Nasdaq slumped 2.01%, with the Nasdaq nearly in correction at down 9.65% since late October. The conflict raised energy prices, elevating inflation concerns and complicating central bank policies. Treasury yields surged, with the 10-year yield reaching 4.39%, the highest since July. Gold plunged 2% on Friday, marking a 10% weekly loss. Brent crude rose 3.26% to $112.19 per barrel. Market uncertainty persists over conflict duration and oil prices, with investors cautious about further downside.